Zogenix Sues State of Massachusetts Over Pain-Killer Ban; Shares Rise Nearly 3%
Bristol-Myers Squibb Up 1% on New Drug Applications
Recently, Bristol-Myers Squibb (BMY) submitted new drug applications to the U.S. Food and Drug Administration (FDA).
Zogenix Sues State of Massachusetts Over Pain-Killer Ban; Shares Rise Nearly 3%
Recently, Bristol-Myers Squibb (BMY) submitted new drug applications to the U.S. Food and Drug Administration (FDA).